107 related articles for article (PubMed ID: 28716427)
1. Influence of L-dopa on subtle motor signs in heterozygous Parkin- and PINK1 mutation carriers.
Weissbach A; König IR; Hückelheim K; Pramstaller PP; Werner E; Brüggemann N; Tadic V; Lohmann K; Bäumer T; Münchau A; Kasten M; Klein C
Parkinsonism Relat Disord; 2017 Sep; 42():95-99. PubMed ID: 28716427
[TBL] [Abstract][Full Text] [Related]
2. Abnormal premotor-motor interaction in heterozygous Parkin- and Pink1 mutation carriers.
Weissbach A; Bäumer T; Pramstaller PP; Brüggemann N; Tadic V; Chen R; Klein C; Münchau A
Clin Neurophysiol; 2017 Jan; 128(1):275-280. PubMed ID: 27843055
[TBL] [Abstract][Full Text] [Related]
3. Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia.
Binkofski F; Reetz K; Gaser C; Hilker R; Hagenah J; Hedrich K; van Eimeren T; Thiel A; Büchel C; Pramstaller PP; Siebner HR; Klein C
Neurology; 2007 Aug; 69(9):842-50. PubMed ID: 17724286
[TBL] [Abstract][Full Text] [Related]
4. Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism.
Moro E; Volkmann J; König IR; Winkler S; Hiller A; Hassin-Baer S; Herzog J; Schnitzler A; Lohmann K; Pinsker MO; Voges J; Djarmatic A; Seibler P; Lozano AM; Rogaeva E; Lang AE; Deuschl G; Klein C
Neurology; 2008 Apr; 70(14):1186-91. PubMed ID: 18378882
[TBL] [Abstract][Full Text] [Related]
5. Progression of subtle motor signs in PINK1 mutation carriers with mild dopaminergic deficit.
Eggers C; Schmidt A; Hagenah J; Brüggemann N; Klein JC; Tadic V; Kertelge L; Kasten M; Binkofski F; Siebner H; Neumaier B; Fink GR; Hilker R; Klein C
Neurology; 2010 Jun; 74(22):1798-805. PubMed ID: 20513816
[TBL] [Abstract][Full Text] [Related]
6. Heterozygous carriers of a Parkin or PINK1 mutation share a common functional endophenotype.
van Nuenen BF; Weiss MM; Bloem BR; Reetz K; van Eimeren T; Lohmann K; Hagenah J; Pramstaller PP; Binkofski F; Klein C; Siebner HR
Neurology; 2009 Mar; 72(12):1041-7. PubMed ID: 19038850
[TBL] [Abstract][Full Text] [Related]
7. Responsiveness to distracting stimuli, though increased in Parkinson's disease, is decreased in asymptomatic PINK1 and Parkin mutation carriers.
Verleger R; Hagenah J; Weiss M; Ewers T; Heberlein I; Pramstaller PP; Siebner HR; Klein C
Neuropsychologia; 2010 Jan; 48(2):467-76. PubMed ID: 19822161
[TBL] [Abstract][Full Text] [Related]
8. Compensatory premotor activity during affective face processing in subclinical carriers of a single mutant Parkin allele.
Anders S; Sack B; Pohl A; Münte T; Pramstaller P; Klein C; Binkofski F
Brain; 2012 Apr; 135(Pt 4):1128-40. PubMed ID: 22434215
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of the parkin and PINK1 genes in American Caucasian early-onset Parkinson disease families.
Deng H; Le W; Shahed J; Xie W; Jankovic J
Neurosci Lett; 2008 Jan; 430(1):18-22. PubMed ID: 18068301
[TBL] [Abstract][Full Text] [Related]
10. Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit?
Hedrich K; Hagenah J; Djarmati A; Hiller A; Lohnau T; Lasek K; Grünewald A; Hilker R; Steinlechner S; Boston H; Kock N; Schneider-Gold C; Kress W; Siebner H; Binkofski F; Lencer R; Münchau A; Klein C
Arch Neurol; 2006 Jun; 63(6):833-8. PubMed ID: 16769864
[TBL] [Abstract][Full Text] [Related]
11. Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: an 18F-dopa PET progression study.
Pavese N; Khan NL; Scherfler C; Cohen L; Brooks DJ; Wood NW; Bhatia KP; Quinn NP; Lees AJ; Piccini P
Mov Disord; 2009 Nov; 24(15):2260-6. PubMed ID: 19845000
[TBL] [Abstract][Full Text] [Related]
12. Mapping preclinical compensation in Parkinson's disease: an imaging genomics approach.
van Nuenen BF; van Eimeren T; van der Vegt JP; Buhmann C; Klein C; Bloem BR; Siebner HR
Mov Disord; 2009; 24 Suppl 2():S703-10. PubMed ID: 19877238
[TBL] [Abstract][Full Text] [Related]
13. [Molecular genetics of PINK1].
Funayama M; Hattori N
Brain Nerve; 2007 Aug; 59(8):831-8. PubMed ID: 17713119
[TBL] [Abstract][Full Text] [Related]
14. Frequency of heterozygous Parkin mutations in healthy subjects: need for careful prospective follow-up examination of mutation carriers.
Brüggemann N; Mitterer M; Lanthaler AJ; Djarmati A; Hagenah J; Wiegers K; Winkler S; Pawlack H; Lohnau T; Pramstaller PP; Klein C; Lohmann K
Parkinsonism Relat Disord; 2009 Jul; 15(6):425-9. PubMed ID: 19162522
[TBL] [Abstract][Full Text] [Related]
15. Somatosensory processing in a German family with PINK1 mutations: its potential role in Parkinson disease.
Gierthmühlen J; Lienau F; Maag R; Hagenah JM; Deuschl G; Fritzer E; Klein C; Baron R; Helmchen C
J Neurol Neurosurg Psychiatry; 2009 May; 80(5):571-4. PubMed ID: 19372294
[TBL] [Abstract][Full Text] [Related]
16. In vivo assessment of brain monoamine systems in parkin gene carriers: a PET study.
Pavese N; Moore RY; Scherfler C; Khan NL; Hotton G; Quinn NP; Bhatia KP; Wood NW; Brooks DJ; Lees AJ; Piccini P
Exp Neurol; 2010 Mar; 222(1):120-4. PubMed ID: 20043906
[TBL] [Abstract][Full Text] [Related]
17. Familial Parkinsonism with digenic parkin and PINK1 mutations.
Funayama M; Li Y; Tsoi TH; Lam CW; Ohi T; Yazawa S; Uyama E; Djaldetti R; Melamed E; Yoshino H; Imamichi Y; Takashima H; Nishioka K; Sato K; Tomiyama H; Kubo S; Mizuno Y; Hattori N
Mov Disord; 2008 Jul; 23(10):1461-5. PubMed ID: 18546294
[TBL] [Abstract][Full Text] [Related]
18. Task matters - challenging the motor system allows distinguishing unaffected Parkin mutation carriers from mutation-free controls.
Prasuhn J; Borsche M; Hicks AA; Gögele M; Egger C; Kritzinger C; Pichler I; Castelo-Rueda MP; Langlott L; Kasten M; Mascalzoni D; Klein C; Pramstaller PP; Brüggemann N
Parkinsonism Relat Disord; 2021 May; 86():101-104. PubMed ID: 33895538
[TBL] [Abstract][Full Text] [Related]
19. Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study.
Khan NL; Brooks DJ; Pavese N; Sweeney MG; Wood NW; Lees AJ; Piccini P
Brain; 2002 Oct; 125(Pt 10):2248-56. PubMed ID: 12244082
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the role of heterozygous mutations in genes associated with parkinsonism.
Klein C; Lohmann-Hedrich K; Rogaeva E; Schlossmacher MG; Lang AE
Lancet Neurol; 2007 Jul; 6(7):652-62. PubMed ID: 17582365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
